Highlights Chugai Pharmaceutical Co., Ltd

Equities

4519

JP3519400000

Delayed Japan Exchange Other stock markets 12:07:27 2024-04-30 am EDT			5-day change	1st Jan Change
5,061 ^JPY	+4.31%		-2.37%	-5.24%

Apr. 25	Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5%	MT
Apr. 24	Chugai Pharmaceutical's Profit Slightly Up in Q1	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5%	Apr. 25	MT
Chugai Pharmaceutical's Profit Slightly Up in Q1	Apr. 24	MT
Japan's Nikkei slips on caution ahead of US inflation data	Apr. 09	RE
Chugai Pharmaceutical to Allocate 594 Million Yen of Treasury Shares as Restricted Stock Compensation	Mar. 29	MT
Roche's Chugai Wins Japanese Approval for Piasky Injection	Mar. 27	MT
Global markets live: Sanofi, ABB, Qualcomm, Roche, Shell...	Feb. 01
Chugai Pharmaceutical’s Profit Down 13% in 2023	Feb. 01	MT
Chugai Pharmaceutical Co., Ltd. Provides Consolidated Non-Audited Earnings Guidance for the Financial Year 2024	Feb. 01	CI
Final dividend	Dec. 27	FA
From scandal to delisting: Toshiba's long-running crisis	Dec. 19	RE
Chugai Pharmaceutical’s Attributable Profit down 13.9% in Fiscal due to One-Off Lump-Sum Settlement;Shares Shed over 2.6%	23-10-24	MT
Chugai Parent Roche Settles US Lawsuit Against Biogen Over Alleged Biosimilar Infringement	23-10-24	MT
Chugai Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Nine Months and Financial Year Ending December 31, 2023	23-10-24	CI
Chugai Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending December 31, 2023	23-10-24	CI
Roche, Biogen Settle US Patent Infringement Case Over Actemra Biosimilar	23-10-23	MT
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug	23-10-23	RE
Chugai Pharmaceutical Files Patent Infringement Lawsuit Against Biogen, Bio-Thera	23-07-18	MT
Ex-dividend day for interim dividend	23-06-28	FA
Chugai Pharmaceutical's Fiscal Q1 Net Income Falls 44.2%	23-04-28	MT
Chugai Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending December 2023	23-04-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Chugai Pharmaceutical Co., Ltd

Equities

4519

JP3519400000

Highlights

Filters